E Fund Management Co., Ltd. Ligand Pharmaceuticals Inc Transaction History

E Fund Management Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $7 - $77,228	-718 Reduced 22.29%	2,503 $216,000
Q2 2022 Aug 15, 2022	BUY	$74.52 - $117.06 $61,255 - $96,223	822 Added 34.26%	3,221 $287,000
Q1 2022 May 12, 2022	BUY	$94.99 - $151.56 $147,994 - $236,130	1,558 Added 185.26%	2,399 $270,000
Q1 2021 May 12, 2021	BUY	$99.52 - $215.83 $83,696 - $181,513	841 New	841 $128,000

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.86B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.